Associate Professor

Department of Plastic and Reconstructive Surgery
Tokyo Medical University, Japan

Dr. Miki Fujii is a board-certified plastic and reconstructive surgeon specializing in diabetic foot management, with a particular focus on limb salvage and chronic wound healing. She currently serves as Associate Professor at Tokyo Medical University, where she leads clinical and research initiatives aimed at improving outcomes for patients with complex diabetic foot conditions.

Dr. Fujii earned her medical degree from Kanazawa University and has dedicated her career to reconstructive and regenerative surgical techniques in Kobe University. She further enhanced her expertise through a visiting scholarship at the Southern Arizona Limb Salvage Alliance (SALSA), University of Arizona, under the mentorship of Prof. David G. Armstrong—deepening her global perspective on limb preservation strategies.

Her research focuses on multidisciplinary approaches to diabetic limb salvage, including advanced imaging for osteomyelitis, novel apheresis therapies for no-option chronic limb-threatening ischemia, and biologic materials for tissue regeneration. She has published extensively in peer-reviewed journals and has received numerous honors, including the Best Free Paper Award at The Wound Meeting and the Dr. Robert W. Hobson II Award at the Diabetic Limb Salvage Conference.

Dr. Fujii is actively engaged in several national and international professional societies. She currently serves as a board member of the Japan Society of Plastic and Reconstructive Surgery, the Japanese Society for Surgical Wound Care, the Japanese Society for Wound Healing, the Japanese Society for Foot Care and Podiatric Medicine, and the Japanese Society of Pressure Ulcers. Additionally, she is an executive board member of the International Association of Diabetic Foot Surgeons (IADFS).

As a member of the IWGDF Wound Healing Interventions Working Group, Dr. Fujii contributes her extensive expertise to the global development of evidence-based guidelines, with the goal of improving diabetic foot care and reducing preventable amputations worldwide.